EU Health Regulator Clears Use of AI Tool in Fatty Liver Disease Trials
(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...
NL Times1d
European Medicines Agency gives first green light to AI use citing liver biopsy trial
The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...
EU Medicines Agency assesses first AI diagnosis as "scientifically valid"
For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...
News247h
A jab that could protect against HIV for a year at a time
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
European Medicines Agency: Interactive map provides information on studies
The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...
Commission to push 'buy European' in new critical medicines act
The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical ...
The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental'
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not been formally approved and that millions have therefore been vaccinated ...
Alnylam's Amvuttra Secures FDA Approval For Expanded Use For Rare Heart Disease, Stock Jumps
The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...
The American Journal of Managed Care9d
Uniform Global Standards, Processes Could Accelerate CGT Approvals, Access
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
Business Wire26d
European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...
The Manila Times2d
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
The Independent3d
Africa’s ambitious push for vaccine independence
Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...